A new pathway of glucocorticoid action for asthma treatment through the regulation of PTEN expression
<p>Abstract</p> <p>Background</p> <p>"Phosphatase and tensin homolog deleted on chromosome 10" (PTEN) is mostly considered to be a cancer-related gene, and has been suggested to be a new pathway of pathogenesis of asthma. The purpose of this study was to inves...
Main Authors: | Chen Qingge, Zhang Lei, Yang Wei, Cai ZhuYing, Tang JiHong, Ni ZhenHua, Zhang Long, Wang XiongBiao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/12/1/47 |
Similar Items
-
Glucocorticoids and mepolizumab in eosinophilic asthma.
by: Bel, E, et al.
Published: (2014) -
Drug Repurposing to Treat Glucocorticoid Resistance in Asthma
by: Alberta L. Wang, et al.
Published: (2021-03-01) -
Is there a role for glucocorticoid receptor beta in asthma?
by: Gagliardo Rosalia, et al.
Published: (2000-12-01) -
Mitochondrial Glucocorticoid Receptors and Their Actions
by: Ioanna Kokkinopoulou, et al.
Published: (2021-06-01) -
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
by: Bel, E, et al.
Published: (2014)